Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1 2 or 4 weeks
| dc.article.end-page | 13 | en |
| dc.article.start-page | 1 | en |
| dc.citation.doi | 10.1016/J.RPTH.2023.102306 | en |
| dc.contributor.author | A Kiialainen | en |
| dc.contributor.author | J I Adamkewicz | en |
| dc.contributor.author | C Petry | en |
| dc.contributor.author | J Oldenburg | en |
| dc.contributor.author | E et al | en |
| dc.contributor.author | Johnny Mahlangu | en |
| dc.date.accessioned | 2024-09-18T11:27:51Z | |
| dc.date.available | 2024-09-18T11:27:51Z | |
| dc.faculty | FACULTY OF HEALTH SCIENCES | en |
| dc.identifier.citation | WOS | en |
| dc.identifier.issn | 2475-0379 | en |
| dc.identifier.uri | https://hdl.handle.net/10539/40941 | |
| dc.journal.title | Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1 2 or 4 weeks | en |
| dc.journal.volume | 8 | en |
| dc.title | Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1 2 or 4 weeks | en |
| dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal Article.pdf
- Size:
- 2.28 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client